Dec 21, 2018 - Profit margins are north of 20%.CSL has a high moat is it is difficult to enter the plasma business.CSL is by far the largest plasma company in the world.
Oct 16, 2018 - October's top net gain safer Healthcare WallStar is AbbVie. Its projected 23% net gain was 2.3% better than Sanofi's, and 3.4% more than Grifol's result per analyst targets of 10/12/18.WallStars all s
Oct 15, 2018 - Big pharma drug makers and biotech continued to top the healthcare sector by broker targets. WallStars are distinguished by positive broker target price upsides.The Healthcare sector is comprised of 1
Sep 17, 2018 - Is Grifols, S.A. (GRFS) a great pick from the value investor's perspective right now? Read on to know more.
Sep 12, 2018 - Gilead took September's net gain safer Healthcare WallStar top spot. Its projected 21.82% net gain was 3% better than AbbVie's, and 29% more than Grifol's result, per analyst targets 9/10/18.WallStars
Sep 12, 2018 - But for PMD, Big pharma drug makers and biotech continued to top the healthcare sector by yield and broker targets. WallStars are distinguished by positive broker target price upsides.The Healthcare s
Jun 01, 2018 - Barclays issues rating change for GRFS
May 31, 2018 - Grifols S.A. (NASDAQ:GRFS) had declared $0.250975/share semi-annual dividend.Payable June 5; for shareholders of record May 31; ex-div June 1.
May 24, 2018 - Gilead took net gain safer May dividend Healthcare WallStar honors. Its 27.4% net gain was 23% better than Sanofi's, and 32% ahead of AmerisourceBergen's result per analyst targets of 5/22/18.22 of 31
May 22, 2018 - Payments processor serving the niche plasma donation market. Share winner in a growing industry with revenue potentially 4-8x higher in four years.Strong financial profile with high margins, ROIC, and